Extract from the Register of European Patents

EP About this file: EP3723827

EP3723827 - MEDICATION DELIVERY DEVICE WITH SYRINGE SENSING SYSTEM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.03.2026
Database last updated on 09.04.2026
FormerThe patent has been granted
Status updated on  04.04.2025
FormerGrant of patent is intended
Status updated on  22.12.2024
FormerExamination is in progress
Status updated on  07.04.2023
FormerRequest for examination was made
Status updated on  18.09.2020
FormerThe international publication has been made
Status updated on  21.06.2019
Formerunknown
Status updated on  11.01.2019
Most recent event   Tooltip13.03.2026No opposition filed within time limitpublished on 15.04.2026 [2026/16]
Applicant(s)For all designated states
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285 / US
[2020/43]
Inventor(s)01 / LOUGHNANE, Christopher Paul
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288 / US
02 / ROHATGI, Gaurav
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288 / US
03 / SNYDER, Stephen Louis
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288 / US
 [2020/43]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2025/19]
Former [2020/43]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date18826881.706.12.2018
[2020/43]
WO2018US64177
Priority number, dateUS201762599029P15.12.2017         Original published format: US 201762599029 P
[2020/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019118261
Date:20.06.2019
Language:EN
[2019/25]
Type: A1 Application with search report 
No.:EP3723827
Date:21.10.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 20.06.2019 takes the place of the publication of the European patent application.
[2020/43]
Type: B1 Patent specification 
No.:EP3723827
Date:07.05.2025
Language:EN
[2025/19]
Search report(s)International search report - published on:EP20.06.2019
ClassificationIPC:A61M5/20, A61M5/315, A61M5/32
[2020/43]
CPC:
A61M5/2033 (EP,IL,KR,US); A61M5/3157 (EP,IL,KR,US); A61M5/31568 (KR);
A61M5/31576 (KR); A61M5/31583 (US); A61M5/3234 (EP,IL,KR,US);
A61M2005/206 (EP,IL,KR,US); A61M2005/2073 (EP,IL,KR,US); A61M2005/3125 (KR);
A61M2005/3254 (KR); A61M2205/3306 (KR,US); A61M2205/3327 (EP,IL,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/43]
Extension statesBA28.05.2020
ME28.05.2020
Validation statesMA28.05.2020
MD28.05.2020
TitleGerman:MEDIKAMENTENABGABEVORRICHTUNG MIT SPRITZENERFASSUNGSSYSTEM[2020/43]
English:MEDICATION DELIVERY DEVICE WITH SYRINGE SENSING SYSTEM[2020/43]
French:DISPOSITIF D'ADMINISTRATION DE MÉDICAMENT DOTÉ D'UN SYSTÈME DE DÉTECTION DE SERINGUE[2020/43]
Entry into regional phase28.05.2020National basic fee paid 
28.05.2020Designation fee(s) paid 
28.05.2020Examination fee paid 
Examination procedure28.05.2020Examination requested  [2020/43]
28.05.2020Date on which the examining division has become responsible
22.01.2021Amendment by applicant (claims and/or description)
12.04.2023Despatch of a communication from the examining division (Time limit: M04)
18.07.2023Reply to a communication from the examining division
15.09.2023Despatch of a communication from the examining division (Time limit: M04)
12.01.2024Reply to a communication from the examining division
23.12.2024Communication of intention to grant the patent
02.04.2025Fee for grant paid
02.04.2025Fee for publishing/printing paid
02.04.2025Receipt of the translation of the claim(s)
Divisional application(s)EP23185932.3  / EP4252803
Opposition(s)10.02.2026No opposition filed within time limit [2026/16]
Fees paidRenewal fee
14.12.2020Renewal fee patent year 03
30.11.2021Renewal fee patent year 04
13.10.2022Renewal fee patent year 05
11.10.2023Renewal fee patent year 06
19.12.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipSM07.05.2025
[2026/08]
Cited inInternational search[YD] WO2011109205  (LILLY CO ELI et al.)
 [YD] EP3199188  (CAREBAY EUROPE LTD et al.) [YD] 1-26 * page 6, line 13 - line 21 * * page 22, line 7 - line 25 * * page 23, line 9 - page 24, line 4 * * figures 1-19 *
 [Y] WO2006134153  (NOVO NORDISK AS et al.) [Y] 1-26 * paragraph [0066] - paragraph [0076] * * paragraph [0098] - paragraph [0099] * * paragraph [0108] - paragraph [0111] *
 [Y] WO2016140853  (BIOGEN MA INC et al.) [Y] 1-26 * page 2, paragraph 4 * * page 3, paragraph 5 - page 4, paragraph 2 * * page 5, paragraph 1 * * figure 1 *
 [Y] US2016193415  (COWE TOBY et al.) [Y] 22-26 * paragraph [0006] - paragraph [0007] * * paragraph [0057] * * paragraph [0061] - paragraph [0062] * * figure 2E *
by applicantUS8734394
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.